{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:53:21Z","timestamp":1787748801053,"version":"build-2784847793"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ccl.2020.04.008","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T17:31:14Z","timestamp":1591637474000},"page":"445-456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Congenital Heart Disease and Pulmonary Hypertension"],"prefix":"10.1016","volume":"38","author":[{"given":"Andrew","family":"Constantine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Opotowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ccl.2020.04.008_bib1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijcard.2006.09.017","article-title":"Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry","volume":"120","author":"Duffels","year":"2007","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.ccl.2020.04.008_bib2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijcard.2014.04.072","article-title":"Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification","volume":"174","author":"van Riel","year":"2014","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.ccl.2020.04.008_bib3","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/hrt.2006.098848","article-title":"Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease","volume":"93","author":"Engelfriet","year":"2007","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ccl.2020.04.008_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCULATIONAHA.109.883876","article-title":"Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension","volume":"121","author":"Dimopoulos","year":"2010","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.ccl.2020.04.008_bib5","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1016\/j.jacc.2017.03.597","article-title":"Left main coronary artery compression in patients with pulmonary arterial hypertension and angina","volume":"69","author":"Gali\u00e8","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ccl.2020.04.008_bib6","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"Eur Respir J"},{"issue":"Suppl 2","key":"10.1016\/j.ccl.2020.04.008_bib7","doi-asserted-by":"crossref","first-page":"ii14","DOI":"10.1136\/heartjnl-2014-307200","volume":"102","author":"Koestenberger","year":"2016","journal-title":"Heart"},{"issue":"22","key":"10.1016\/j.ccl.2020.04.008_bib8","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1016\/j.jacc.2018.08.2201","article-title":"Echocardiographic screening for pulmonary hypertension in congenital heart disease","volume":"72","author":"Dimopoulos","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2020.04.008_bib9","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ccl.2020.04.008_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/CIRCULATIONAHA.112.111302","article-title":"Hemodynamic responses to rapid saline loading: the impact of age, sex, and heart failure","volume":"127","author":"Fujimoto","year":"2013","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccl.2020.04.008_bib11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1161\/CIRCHEARTFAILURE.113.000468","article-title":"High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension","volume":"7","author":"Robbins","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"12 Suppl 1","key":"10.1016\/j.ccl.2020.04.008_bib12","first-page":"I76","article-title":"Inhaled nitric oxide as a preoperative test (INOP test I): the INOP test study group","volume":"106","author":"Balzer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2020.04.008_bib13","first-page":"25255","article-title":"2018 AHA\/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","author":"Stout","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ccl.2020.04.008_bib14","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.athoracsur.2007.01.019","article-title":"Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices","volume":"83","author":"Etz","year":"2007","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.ccl.2020.04.008_bib15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.healun.2009.09.013","article-title":"Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension","volume":"29","author":"Nair","year":"2010","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"7","key":"10.1016\/j.ccl.2020.04.008_bib16","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1161\/01.CIR.0000138741.72946.84","article-title":"Novel method of quantifying pulmonary vascular resistance by use of simultaneous invasive pressure monitoring and phase-contrast magnetic resonance flow","volume":"110","author":"Muthurangu","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ccl.2020.04.008_bib17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/01.CIR.18.4.533","article-title":"The pathology of hypertensive pulmonary vascular disease","volume":"18","author":"Heath","year":"1958","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ccl.2020.04.008_bib18","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/01.CIR.58.6.1107","article-title":"Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease","volume":"58","author":"Rabinovitch","year":"1978","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ccl.2020.04.008_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/path.1711520304","article-title":"Pulmonary vascular disease in ventricular septal defect: structural and functional correlations in lung biopsies from 85 patients, with outcome of intracardiac repair","volume":"152","author":"Haworth","year":"1987","journal-title":"J\u00a0Pathol"},{"issue":"12 Supplement","key":"10.1016\/j.ccl.2020.04.008_bib20","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jacc.2004.02.037","article-title":"Clinical classification of pulmonary hypertension","volume":"43","author":"Simonneau","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ccl.2020.04.008_bib21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijcard.2008.02.004","article-title":"Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy","volume":"129","author":"Dimopoulos","year":"2008","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ccl.2020.04.008_bib22","first-page":"675","article-title":"Pulmonary vascular obstructive disease","volume":"11","author":"Collins-Nakai","year":"1993","journal-title":"Cardiol Clin"},{"issue":"5","key":"10.1016\/j.ccl.2020.04.008_bib23","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/0002-9149(65)90047-0","article-title":"The natural history of ventricular septal defects in infancy","volume":"16","author":"Hoffman","year":"1965","journal-title":"Am J Cardiol"},{"issue":"17","key":"10.1016\/j.ccl.2020.04.008_bib24","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/heartjnl-2016-310979","article-title":"Epidemiological changes in Eisenmenger syndrome in the Nordic region in 1977-2012","volume":"103","author":"Hjortsh\u00f8j","year":"2017","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.ccl.2020.04.008_bib25","article-title":"The changing landscape of pulmonary arterial hypertension in the adult with congenital heart disease","volume":"6","author":"van Dissel","year":"2017","journal-title":"J\u00a0Clin Med"},{"issue":"9","key":"10.1016\/j.ccl.2020.04.008_bib26","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jacc.2015.06.1318","article-title":"Lifetime risk of pulmonary hypertension for all patients after shunt closure","volume":"66","author":"van Riel","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2020.04.008_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2019.12.070","article-title":"Pulmonary hypertension after shunt closure in patients with simple congenital heart defects","author":"Lammers","year":"2020","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2020.04.008_bib28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13073-018-0566-x","article-title":"Rare variants in SOX17 are associated with pulmonary arterial hypertension with congenital heart disease","volume":"10","author":"Zhu","year":"2018","journal-title":"Genome Med"},{"issue":"3","key":"10.1016\/j.ccl.2020.04.008_bib29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1183\/09031936.04.00018604","article-title":"BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease","volume":"24","author":"Roberts","year":"2004","journal-title":"Eur Respir J"},{"issue":"14","key":"10.1016\/j.ccl.2020.04.008_bib30","article-title":"Definition and management of segmental pulmonary hypertension","volume":"7","author":"Dimopoulos","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"25 Suppl","key":"10.1016\/j.ccl.2020.04.008_bib31","doi-asserted-by":"crossref","first-page":"D100","DOI":"10.1016\/j.jacc.2013.10.033","article-title":"Pulmonary hypertension due to left heart diseases","volume":"62","author":"Vachi\u00e9ry","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.ccl.2020.04.008_bib32","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/eurheartj\/eht437","article-title":"Pulmonary hypertension related to congenital heart disease: a call for action","volume":"35","author":"Dimopoulos","year":"2014","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ccl.2020.04.008_bib33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.106.630715","article-title":"Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study","volume":"114","author":"Gali\u00e8","year":"2006","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ccl.2020.04.008_bib34","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/eurheartj\/ehq011","article-title":"Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial","volume":"31","author":"Iversen","year":"2010","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ccl.2020.04.008_bib35","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1747-0803.2011.00561.x","article-title":"Clinical efficacy of phosphodiesterase-5 inhibitor tadalafil in Eisenmenger syndrome\u2014a randomized, placebo-controlled, double-blind crossover study","volume":"6","author":"Mukhopadhyay","year":"2011","journal-title":"Congenit Heart Dis"},{"issue":"3","key":"10.1016\/j.ccl.2020.04.008_bib36","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijcard.2010.10.051","article-title":"Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology","volume":"155","author":"D\u2019Alto","year":"2012","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2020.04.008_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCULATIONAHA.118.033575","article-title":"Evaluation of macitentan in patients with Eisenmenger syndrome","volume":"139","author":"Gatzoulis","year":"2019","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.ccl.2020.04.008_bib38","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/eurheartj\/ehv743","article-title":"Current therapy and outcome of Eisenmenger syndrome: data of the German National Register for congenital heart defects","volume":"37","author":"Diller","year":"2016","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ccl.2020.04.008_bib39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.acvd.2017.01.006","article-title":"Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: a French multicentre study","volume":"110","author":"Hascoet","year":"2017","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.ccl.2020.04.008_bib40","article-title":"Pulmonary vasodilator therapy is associated with greater survival in Eisenmenger syndrome","author":"Arnott","year":"2017","journal-title":"Heart"},{"issue":"11","key":"10.1016\/j.ccl.2020.04.008_bib41","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/eurheartj\/eht072","article-title":"Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups","volume":"35","author":"Manes","year":"2014","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ccl.2020.04.008_bib42","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/S0735-1097(01)01635-7","article-title":"Surgical treatment for secundum atrial septal defects in patients\u00a0>40 years old. A randomized clinical trial","volume":"38","author":"Attie","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ccl.2020.04.008_bib43","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/eurheartj\/ehq352","article-title":"Benefit of atrial septal defect closure in adults: impact of age","volume":"32","author":"Humenberger","year":"2011","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ccl.2020.04.008_bib44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1253\/circj.CJ-15-1235","article-title":"\u201cTreat-and-repair\u201d strategy for atrial septal defect and associated pulmonary arterial hypertension","volume":"80","author":"Yao","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.ccl.2020.04.008_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2019.03.056","article-title":"\u201cTreat-to-close\u201d: non-repairable ASD-PAH in the adult: results from the North American ASD-PAH (NAAP) multicenter registry","author":"Bradley","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ccl.2020.04.008_bib46","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijcard.2019.05.039","article-title":"Evaluating a strategy of PAH therapy pre-treatment in patients with atrial septal defects and pulmonary arterial hypertension to permit safe repair (\u201ctreat-and-repair\u201d)","volume":"291","author":"Constantine","year":"2019","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.ccl.2020.04.008_bib47","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1016\/j.jtcvs.2013.10.052","article-title":"Unidirectional valved patch closure of ventricular septal defects with severe pulmonary arterial hypertension: hemodynamic outcomes","volume":"148","author":"Talwar","year":"2014","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"9","key":"10.1016\/j.ccl.2020.04.008_bib48","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension","volume":"369","author":"Pulido","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.ccl.2020.04.008_bib49","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMoa1503184","article-title":"Selexipag for the treatment of pulmonary arterial hypertension","volume":"373","author":"Sitbon","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.ccl.2020.04.008_bib50","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/eurheartj\/ehn215","article-title":"Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients","volume":"29","author":"Giardini","year":"2008","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ccl.2020.04.008_bib51","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1017\/S1047951109990023","article-title":"The effect of bosentan in patients with a failing Fontan circulation","volume":"19","author":"Ovaert","year":"2009","journal-title":"Cardiol Young"},{"issue":"11","key":"10.1016\/j.ccl.2020.04.008_bib52","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.110.981746","article-title":"Impact of oral sildenafil on exercise performance in children and young adults after the Fontan operation: a randomized, double-blind, placebo-controlled, crossover trial","volume":"123","author":"Goldberg","year":"2011","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ccl.2020.04.008_bib53","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/eurjhf\/hft017","article-title":"Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial","volume":"15","author":"Schuuring","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.ccl.2020.04.008_bib54","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.ijcard.2013.03.014","article-title":"Effect of inhaled iloprost on the exercise function of Fontan patients: a demonstration of concept","volume":"168","author":"Rhodes","year":"2013","journal-title":"Int J Cardiol"},{"issue":"23","key":"10.1016\/j.ccl.2020.04.008_bib55","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1161\/CIRCULATIONAHA.113.008441","article-title":"Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (Treatment with Endothelin receptor antagonist in Fontan patients, a randomized, placebo-controlled, double-blind study Measuring Peak Oxygen Consumption) study","volume":"130","author":"Hebert","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2020.04.008_bib56","article-title":"Results of the Fontan Udenafil Exercise Longitudinal (FUEL) trial","author":"Goldberg","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2020.04.008_bib57","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijcard.2019.06.031","article-title":"Sacubitril\/valsartan for heart failure in adults with complex congenital heart disease","volume":"300","author":"Maurer","year":"2020","journal-title":"Int J Cardiol"},{"issue":"15","key":"10.1016\/j.ccl.2020.04.008_bib58","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/CIRCULATIONAHA.116.023033","article-title":"Predictors of death in contemporary adult patients with Eisenmenger syndrome: a multicenter study","volume":"135","author":"Kempny","year":"2017","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccl.2020.04.008_bib59","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01916-2018","article-title":"Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management","volume":"53","author":"Rosenzweig","year":"2019","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ccl.2020.04.008_bib60","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jcin.2018.10.045","article-title":"Pulmonary\u00a0artery denervation: a new, long-awaited interventional treatment for combined pre- and post-capillary pulmonary hypertension?","volume":"12","author":"Dimopoulos","year":"2019","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386512030031X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386512030031X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:51:19Z","timestamp":1760007079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073386512030031X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S073386512030031X"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2020.04.008","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Congenital Heart Disease and Pulmonary Hypertension","name":"articletitle","label":"Article Title"},{"value":"Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccl.2020.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}